UT Southwestern Clements University Hospital
Welcome,         Profile    Billing    Logout  
 0 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mansir, Cheryl
NCT04164173: Hyperinflation Respiratory Therapies in Cardiac Surgery Patients

Recruiting
N/A
324
US
EzPAP, Postoperative hyperinflation therapy-EzPAP, Metaneb, Postoperative hyperinflation therapy-Metaneb, Intermittent Positive Pressure Breathing (IPPB), Postoperative hyperinflation therapy-IPPB
University of Texas Southwestern Medical Center
Pulmonary Disease, Postoperative Complications
08/27
12/27
Odeh, Jaffer
NCT04164173: Hyperinflation Respiratory Therapies in Cardiac Surgery Patients

Recruiting
N/A
324
US
EzPAP, Postoperative hyperinflation therapy-EzPAP, Metaneb, Postoperative hyperinflation therapy-Metaneb, Intermittent Positive Pressure Breathing (IPPB), Postoperative hyperinflation therapy-IPPB
University of Texas Southwestern Medical Center
Pulmonary Disease, Postoperative Complications
08/27
12/27
Monogue, Marguerite
NCT05314764: Cefiderocol Pharmacokinetics in Adult Patients With Cystic Fibrosis

Completed
4
10
US
Cefiderocol, Fetroja
Hartford Hospital, Shionogi Inc., Keystone Bioanalytical, Inc., Indiana University Health Methodist Hospital, University of Pittsburgh Medical Center, University of Texas
Cystic Fibrosis, Pneumonia, Bacterial
06/24
12/24
NCT05561764: Imipenem/Cilastatin/Relebactam Pharmacokinetics, Safety, and Outcomes in Adults and Adolescents With Cystic Fibrosis

Terminated
4
4
US
Imipenem/Cilastatin/Relebactam, Recarbrio
Hartford Hospital, Merck Sharp & Dohme LLC, Q2 Solutions, Connecticut Children's Medical Center, St. Christopher's Hospital for Children, University of Texas Southwestern Medical Center, University of Pittsburgh Medical Center, Indiana University Health Methodist Hospital, James Whitcomb Riley Hospital for Children
Cystic Fibrosis, Pneumonia, Bacterial
10/24
12/24
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mansir, Cheryl
NCT04164173: Hyperinflation Respiratory Therapies in Cardiac Surgery Patients

Recruiting
N/A
324
US
EzPAP, Postoperative hyperinflation therapy-EzPAP, Metaneb, Postoperative hyperinflation therapy-Metaneb, Intermittent Positive Pressure Breathing (IPPB), Postoperative hyperinflation therapy-IPPB
University of Texas Southwestern Medical Center
Pulmonary Disease, Postoperative Complications
08/27
12/27
Odeh, Jaffer
NCT04164173: Hyperinflation Respiratory Therapies in Cardiac Surgery Patients

Recruiting
N/A
324
US
EzPAP, Postoperative hyperinflation therapy-EzPAP, Metaneb, Postoperative hyperinflation therapy-Metaneb, Intermittent Positive Pressure Breathing (IPPB), Postoperative hyperinflation therapy-IPPB
University of Texas Southwestern Medical Center
Pulmonary Disease, Postoperative Complications
08/27
12/27
Monogue, Marguerite
NCT05314764: Cefiderocol Pharmacokinetics in Adult Patients With Cystic Fibrosis

Completed
4
10
US
Cefiderocol, Fetroja
Hartford Hospital, Shionogi Inc., Keystone Bioanalytical, Inc., Indiana University Health Methodist Hospital, University of Pittsburgh Medical Center, University of Texas
Cystic Fibrosis, Pneumonia, Bacterial
06/24
12/24
NCT05561764: Imipenem/Cilastatin/Relebactam Pharmacokinetics, Safety, and Outcomes in Adults and Adolescents With Cystic Fibrosis

Terminated
4
4
US
Imipenem/Cilastatin/Relebactam, Recarbrio
Hartford Hospital, Merck Sharp & Dohme LLC, Q2 Solutions, Connecticut Children's Medical Center, St. Christopher's Hospital for Children, University of Texas Southwestern Medical Center, University of Pittsburgh Medical Center, Indiana University Health Methodist Hospital, James Whitcomb Riley Hospital for Children
Cystic Fibrosis, Pneumonia, Bacterial
10/24
12/24

Download Options